BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3584126)

  • 1. Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7552-8. PubMed ID: 3584126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7559-66. PubMed ID: 3584127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue.
    Blackburn MN; Sibley CC
    J Biol Chem; 1980 Feb; 255(3):824-6. PubMed ID: 7356660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tryptophan residues in heparin-antithrombin interactions.
    Karp GI; Marcum JA; Rosenberg RD
    Arch Biochem Biophys; 1984 Sep; 233(2):712-20. PubMed ID: 6486808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region.
    Dawes J; James K; Lane DA
    Biochemistry; 1994 Apr; 33(14):4375-83. PubMed ID: 7512382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fragment of antithrombin that binds both heparin and thrombin.
    Rosenfeld L; Danishefsky I
    Biochem J; 1986 Aug; 237(3):639-46. PubMed ID: 3800906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.
    Peterson CB; Morgan WT; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7567-74. PubMed ID: 3584128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
    Streusand VJ; Björk I; Gettins PG; Petitou M; Olson ST
    J Biol Chem; 1995 Apr; 270(16):9043-51. PubMed ID: 7721817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of arginine 129 in heparin binding and activation of antithrombin.
    Desai U; Swanson R; Bock SC; Bjork I; Olson ST
    J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rate-determining step of the heparin-catalyzed antithrombin/thrombin reaction is independent of thrombin.
    Pletcher CH; Nelsestuen GL
    J Biol Chem; 1982 May; 257(10):5342-5. PubMed ID: 7068594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
    Danielsson A; Raub E; Lindahl U; Björk I
    J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of heparin with thrombin and antithrombin III.
    Feinman RD; Li EH
    Fed Proc; 1977 Jan; 36(1):51-5. PubMed ID: 830556
    [No Abstract]   [Full Text] [Related]  

  • 19. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
    Andersson LO; Engman L; Henningsson E
    J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.
    Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST
    J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.